The FDA has approved an expanded indication of Soliris, an IV-administered monoclonal antibody for patients aged 6 years and ...

The FDA approved Stoboclo and Osenvelt, denosumab biosimilars that could offer more affordable treatment options for osteoporosis and bone loss in various patient populations. Stoboclo and ...

Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS ...

Back in 2019, Daiichi's Turalio scored its FDA approval based on a 39% overall response rate at Week 25, versus 0% for placebo, also in TGCT patients for whom surgery was not recommended.

If you continue to have this issue please contact [email protected]. Encelto is the first FDA-approved treatment for macular telangiectasia type 2. The cell therapy slows the loss of ...

Encelto, the first FDA-approved treatment for MacTel, is implanted intravitreally during a surgery performed by a qualified ophthalmologist. The Food and Drug Administration (FDA) has approved ...

The approval is only for the 2.5mg tablet. The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with ...

The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.

INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the ... These highlights do not include all the information ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to ... while around 59% of all individuals living with diabetes were not on medication to treat the disease. In 2021, around 1.6 ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved revakinagene taroretcel (Encelto) as the first treatment for adults with idiopathic macular ...